Curaleaf Holdings

Company Description

Curaleaf Holdings, Inc. is an international provider of consumer products in cannabis. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof, provide service, product selection and accessibility across the medical and adult use markets. It has operations in about 17 states and operates 151 dispensaries, 19 cultivation sites and 20 manufacturing facilities, through which it sells cannabis through wholesale channels. The Company places a premium on populated, limited license states, including Arizona, Connecticut, Florida, Illinois, Maryland, Massachusetts, Nevada, New York, New Jersey, North Dakota, Ohio and Pennsylvania. It cultivates, processes, markets and/or dispenses a wide range of permitted cannabis products across its operating markets, including flowers, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, mints and lozenges, topical balms and lotions, tinctures, and others.

Analysis

ANALYSIS: With an Obermatt 360° View of 34 (better than 34% compared with alternatives), overall professional sentiment and financial characteristics for the stock Curaleaf Holdings are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Curaleaf Holdings. The consolidated Growth Rank has a good rank of 60, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 60% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 68, which means that professional investors are more optimistic about the stock than for 68% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 37, which means that the share price of Curaleaf Holdings is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 63% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 13, which means that the company has a financing structure that is riskier than those of 87% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

Country

USA

Industry Pharmaceuticals

Size Small

Website ir.curaleaf.com

Index

Add to Watchlist

See Similar Stocks

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.